GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

briakinumab   Click here for help

GtoPdb Ligand ID: 9213

Synonyms: ABT-874 | J-695 | J695 | Ozespa
Immunopharmacology Ligand
Compound class: Antibody
Comment: Briakinumab is a recombinant, fully human, IgG1 investigational monoclonal antibody targeting the shared p40 subunit of IL-12 and IL-23. Peptide sequences matching those of briakinumab are claimed in patent US6914128 'Human antibodies that bind human IL-12 and methods for producing' [2].
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: pericyazine

Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
9153 briakinumab
Synonyms Click here for help
ABT-874 | J-695 | J695 | Ozespa
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 162
Other databases
GtoPdb PubChem SID 315661289
Search PubMed clinical trials briakinumab
Search PubMed titles briakinumab
Search PubMed titles/abstracts briakinumab